These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10396127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A synthetic overview of new molecules with 5-HT1A binding affinities.
    Pessoa-Mahana H, Araya-Maturana R, Saitz CB, Pessoa-Mahana DC.
    Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
    Paluchowska MH, Dereń-Wesołek A, Mokrosz JL, Charakchieva-Minol S, Chojnacka-Wójcik E.
    Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
    [Abstract] [Full Text] [Related]

  • 8. Is there a role for 5-HT1A agonists in the treatment of depression?
    Blier P, Ward NM.
    Biol Psychiatry; 2003 Feb 01; 53(3):193-203. PubMed ID: 12559651
    [Abstract] [Full Text] [Related]

  • 9. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun 01; 355(6):682-8. PubMed ID: 9205951
    [Abstract] [Full Text] [Related]

  • 10. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML, Ayala D, Benhamú B, Morcillo MJ, Viso A.
    Curr Med Chem; 2002 Feb 01; 9(4):443-69. PubMed ID: 11945120
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
    Wesołowska A, Jastrzębska-Więsek M.
    Int Rev Neurobiol; 2011 Feb 01; 96():49-71. PubMed ID: 21329784
    [No Abstract] [Full Text] [Related]

  • 14. Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data.
    Wesołowska A.
    Pharmacol Rep; 2010 Feb 01; 62(4):564-77. PubMed ID: 20884998
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
    Pranzatelli MR.
    Arch Neurol; 1994 Jun 01; 51(6):605-17. PubMed ID: 7515228
    [Abstract] [Full Text] [Related]

  • 17. Ligand-5-HT1A receptor interaction.
    Chilmonczyk Z.
    Farmaco; 2000 Mar 01; 55(3):191-3. PubMed ID: 10919079
    [Abstract] [Full Text] [Related]

  • 18. Serotonin receptors and therapeutics.
    Launay JM, Callebert J, Bondoux D, Loric S, Maroteaux L.
    Cell Mol Biol (Noisy-le-grand); 1994 May 01; 40(3):327-36. PubMed ID: 7522716
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.